Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) EPS (Basic): 2019-2024

Historic EPS (Basic) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$1.05.

  • Maravai Lifesciences Holdings' EPS (Basic) rose 73.53% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 48.78%. This contributed to the annual value of -$1.05 for FY2024, which is 16.67% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' EPS (Basic) is -$1.05, which was down 16.67% from -$0.90 recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year EPS (Basic) high stood at $7.43 for FY2020, and its period low was -$1.05 during FY2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median EPS (Basic) value was -$0.90 (recorded in 2023), while the average stood at -$0.09.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' EPS (Basic) skyrocketed by 24,866.67% in 2020, and later plummeted by 153.89% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' EPS (Basic) stood at $7.43 in 2020, then plummeted by 78.60% to $1.59 in 2021, then climbed by 5.03% to $1.67 in 2022, then crashed by 153.89% to -$0.90 in 2023, then fell by 16.67% to -$1.05 in 2024.